CRISPR/Cas-based diagnostics are poised to transform precision oncology by enabling faster, cheaper, and more accurate tumor biomarker detection—from genes to proteins to liquid biopsies.

CRISPR is revolutionizing medicine by enabling precise DNA edits, treating genetic diseases like sickle cell anemia and beta-thalassemia, and pioneering in vivo editing and personalized therapies.

For the first of these tasks Dr Baker and his colleagues use RF diffusion, an AI model they have developed to predict a ...

Current CRISPR guide RNAs are designed based on European reference genomes, leading to false-negative results in cells from ...

CAS CAPITAL NO. 1 LTD.DL-FLR NOTES 2021 (26/UND.) (XS2277590209) - All master data, key figures and real-time diagram.

Collection of CRISPR-Cas mutagenised rice plants. (IMAGE) Society for Experimental Biology ...

Police cautions should be removed from database sooner, says Leveson At present, any caution remains on the police national computer until an offender reaches the age of 100, even if it is ‘spent’ ...